glp 1 agonist and dementia GLP-1 the Degenerating Brain: Exploring Mechanistic Insights and Therapeutic Potential Frontiers | Effect and mechanism

However, no GLP-1 receptor agonist is currently licensed specifically for treating inflammatory conditions, and there is no definitive evidence establishing superiority of one agent over another for anti-inflammatory purposes

Glucose-lowering treatments and COVID-19 mortality in T2DM

The difference between patients who took Rezdiffra was just 12%

In June 2025, MBX Biosciences announced that it has submitted an IND application to the FDA for MBX 4291, a long-acting GLP-1/GIP receptor co-agonist prodrug targeting obesity, which received regulatory clearance in July

Hospitalization may be required for persistent vomiting, significant hypoglycemia, or complications such as pancreatitis

Another one covering 55 randomized controlled trials and five observational studies with more than 300,000 participants, drew the same conclusion [60]